Regencell Bioscience Statistics

NASDAQ: RGCHealth Care Medicinal Chemicals and Botanical Products USD

7.63+0.52 (+7.31%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Regencell Bioscience by the numbers

With trailing EPS of $-0.03, Regencell Bioscience is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.5% above its 50-day average and 59.7% below its 200-day average. Average daily trading volume is 199.19K shares, or about $1.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RGC valuation vs. peer median

RGC compared with the median of 8 peer companies
Metric	RGC	Peer median	Difference
Avg. volume	199.19K	1.21M	-83%

Peer median across 8 companies: DFTX, TRLV, TLRY, GLAS, USNA, NAGE, MDWD, BTI.

Valuation

Market cap: —
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-0.03
Shares outstanding: —

Price and trading

Previous close: 7.11
Open: 7.06
Day range: 7.06 – 7.96
52-week range: 4.51 – 69.00
52-week change: -60.67%
50-day moving average: 5.94
200-day moving average: 18.94
Beta: —
Volume: 223.26K
Average volume: 199.19K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Oct 28, 2026

Additional statistics

Eps: -0.03
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 69.00
Week52 Low: 4.51
Avg Volume: 199.19K
Ma50: 5.94
Ma200: 18.94
Earnings Date: Oct 28, 2026
Pct From52w High: -88.94%
Pct From52w Low: 69.18%